Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

INHIBITION OF HIV REPLICATION USING SOLUBLE TAT PEPTIDE ANALOGS

  • Read more about INHIBITION OF HIV REPLICATION USING SOLUBLE TAT PEPTIDE ANALOGS
Patent Cooperation Treaty
PCT/US1997/017704
Filed on 1997-10-02

OLIGONUCLEOTIDES WHICH SPECIFICALLY BIND RETROVIRAL NUCLEOCAPSID PROTEINS

  • Read more about OLIGONUCLEOTIDES WHICH SPECIFICALLY BIND RETROVIRAL NUCLEOCAPSID PROTEINS
Patent Cooperation Treaty
PCT/US1997/008936
Filed on 1997-05-19

SPECIFIC TOLERANCE IN TRANSPLANTATION

  • Read more about SPECIFIC TOLERANCE IN TRANSPLANTATION
US Patent 6,306,651
Filed on 1997-08-13

NOVEL DNA: LIPOSOME COMPLEXES FOR INCREASED SYSTEMIC DELIVERY AND GENE EXPRESSION

  • Read more about NOVEL DNA: LIPOSOME COMPLEXES FOR INCREASED SYSTEMIC DELIVERY AND GENE EXPRESSION
Patent Cooperation Treaty
PCT/US1997/013599
Filed on 1997-08-01

Compositions and Methodsfor Modulatin Proteolytic Degradation of Intracellular Targets.

  • Read more about Compositions and Methodsfor Modulatin Proteolytic Degradation of Intracellular Targets.
US Application 09/096,889
Filed on 1998-06-12

IN VIVO IMAGING AND OXYMETRY BY PULSED RADIOFREQUENCY PARAMAGNETIC RES ONANCECOPY BY PULSED RADIOFREQUENCY ELECTRON PARAMAGNETIC RESONANCE

  • Read more about IN VIVO IMAGING AND OXYMETRY BY PULSED RADIOFREQUENCY PARAMAGNETIC RES ONANCECOPY BY PULSED RADIOFREQUENCY ELECTRON PARAMAGNETIC RESONANCE
US Patent 5,865,746
Filed on 1997-07-29

SIGNAL TRANSDUCTION INHIBITOR COMPOUNDS

  • Read more about SIGNAL TRANSDUCTION INHIBITOR COMPOUNDS
US Patent 5,880,129
Filed on 1997-08-05

METHOD OF INDUCING CELL-MEDIATED PROTECTIVE IMMUNITY AGAINST HIV USING LOW DOSES OF IMMUNOGENS

  • Read more about METHOD OF INDUCING CELL-MEDIATED PROTECTIVE IMMUNITY AGAINST HIV USING LOW DOSES OF IMMUNOGENS
US Application 08/899,081
Filed on 1997-07-23

USE OF NITRIC OXIDE RELEASING COMPOUNDS TO PROTECT NONCANCEROUS CELLS FROM CHEMOTHERAPEUTIC AGENTS

  • Read more about USE OF NITRIC OXIDE RELEASING COMPOUNDS TO PROTECT NONCANCEROUS CELLS FROM CHEMOTHERAPEUTIC AGENTS
US Patent 5,840,759
Filed on 1997-03-11

NOVEL VECTOR FOR POLYNUCLEOTIDE VACCINES

  • Read more about NOVEL VECTOR FOR POLYNUCLEOTIDE VACCINES
Patent Cooperation Treaty
PCT/US1997/014306
Filed on 1997-08-14

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1542
  • Page 1543
  • Page 1544
  • Page 1545
  • Page 1546
  • Page 1547
  • Page 1548
  • Page 1549
  • Page 1550
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health